Format

Send to

Choose Destination
See comment in PubMed Commons below
Br J Nurs. 2013 Jul 11-24;22(13):751-8.

Ventilator-associated pneumonia, liver disease and oral chlorhexldine.

Author information

1
Liver Intensive Therapy Unit, King's College Hospital, London.

Abstract

As part of the ventilator care bundle, the Department of Health (DH) in the U.K. recommends the use of chlorhexidine (CHX) for oral care to prevent the occurrence of ventilator-associated pneumonia (VAP) in all mechanically ventilated patients. Due to the heterogenous nature of this population, however, it is important to consider whether such recommendations are also relevant to specific critical care patient population groups. This article reviews the available scientific evidence on the use of CHX in the prevention of VAP, with a focus on critically ill mechanically ventilated patients who have liver dysfunction. Findings will be discussed with reference to the wider research literature in order to make recommendations for future practice.

PMID:
24261090
DOI:
10.12968/bjon.2013.22.13.751
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Support Center